Physician

Gian Paolo Giuliari Gonzalez, M.D.

According to 2025 Medicare claims, Gian Gonzalez, M.D. (NPI: 1689080236) practices ophthalmology in the Cleveland, OH market, with the plurality of this provider's patient population coming from Lake, OH. This provider's primary affiliated billing organization is VITREO-RETINAL CONSULTANTS, INC. (NPI: 1750347662; TIN: 341390523) and primary practice location at 44060-6017. Gonzalez is affiliated with the Healthcare Solutions Network (ACO ID: A3283), participating under the MSSP model.

Gonzalez's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 504 traditional Medicare patients, billed 5,552 HCPCS/CPT codes, and received $1,161,145 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 188 prescription claims across 70 beneficiaries totaling $7,837 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 1 records totaling $15. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $228,091 and ending at $1,161,145. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $2,124 and ending at $7,837. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$886K$1.8M2018 Medicare payment: $228,091 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,327,688 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,417,860 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,772,257 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $840,293 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $374,336 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,161,145 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018206991$228,091
20195655,476$1,327,688
20204835,628$1,417,860
20215086,207$1,772,257
20225763,297$840,293
20234082,370$374,336
20245045,552$1,161,145

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$18K$35K2015 Drug cost: $2,124 (USD; Tot_Drug_Cst)2016 Drug cost: $6,784 (USD; Tot_Drug_Cst)2017 Drug cost: $2,752 (USD; Tot_Drug_Cst)2018 Drug cost: $2,985 (USD; Tot_Drug_Cst)2019 Drug cost: $17,402 (USD; Tot_Drug_Cst)2020 Drug cost: $12,136 (USD; Tot_Drug_Cst)2021 Drug cost: $35,125 (USD; Tot_Drug_Cst)2022 Drug cost: $10,964 (USD; Tot_Drug_Cst)2023 Drug cost: $7,718 (USD; Tot_Drug_Cst)2024 Drug cost: $7,837 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153053$2,124
201642153$6,784
20172268$2,752
20182764$2,985
201977272$17,402
202079234$12,136
2021109358$35,125
202262134$10,964
20233395$7,718
202470188$7,837

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye151658$86
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more153153$73
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more235386$61
92134Imaging of retina4471,243$28
92201Extended exam of the back part of the eye with retinal drawing345559$17

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate763,601$3,060
DifluprednateDifluprednate16296$1,616
MoxifloxacinMoxifloxacin Hcl45925$1,230
Ketorolac TromethamineKetorolac Tromethamine13652$131

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$15Apellis Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Gian Paolo Giuliari Gonzalez, M.D.?

Tedicare shows public-source Medicare data for Gian Paolo Giuliari Gonzalez, M.D. (NPI 1689080236), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gian Paolo Giuliari Gonzalez, M.D. have ACO affiliation data?

Gian Paolo Giuliari Gonzalez, M.D. is shown with ACO affiliation data for Healthcare Solutions Network (MSSP, ACO ID A3283).

What billing organization is linked to Gian Paolo Giuliari Gonzalez, M.D.?

Gian Paolo Giuliari Gonzalez, M.D. is linked to VITREO-RETINAL CONSULTANTS, INC. (billing NPI 1750347662) in the available physician profile data.

Does Gian Paolo Giuliari Gonzalez, M.D. have Open Payments data?

Gian Paolo Giuliari Gonzalez, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.